A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages

Influenza B viruses (IBV) can cause severe disease and death much like influenza A viruses (IAV), with a disproportionate number of infections in children. Despite moving to a quadrivalent vaccine to include strains from both the B/Victoria and B/Yamagata lineages, vaccine effectiveness rates contin...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlock, Michael A., Ross, Ted M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517972/
https://www.ncbi.nlm.nih.gov/pubmed/37741893
http://dx.doi.org/10.1038/s41598-023-43003-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517972/
https://www.ncbi.nlm.nih.gov/pubmed/37741893
http://dx.doi.org/10.1038/s41598-023-43003-2

Ejemplares similares